These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 36671497

  • 1. Dupilumab Leads to Clinical Improvements including the Acquisition of Tolerance to Causative Foods in Non-Eosinophilic Esophagitis Eosinophilic Gastrointestinal Disorders.
    Arakawa N, Yagi H, Shimizu M, Shigeta D, Shimizu A, Nomura S, Takizawa T, Yamada Y.
    Biomolecules; 2023 Jan 05; 13(1):. PubMed ID: 36671497
    [Abstract] [Full Text] [Related]

  • 2. Successful use of dupilumab for egg-induced eosinophilic gastroenteritis with duodenal ulcer: a pediatric case report and review of literature.
    Tsuge M, Shigehara K, Uda K, Kawano S, Iwamuro M, Saito Y, Yashiro M, Ikeda M, Tsukahara H.
    Allergy Asthma Clin Immunol; 2023 Dec 05; 19(1):103. PubMed ID: 38053199
    [Abstract] [Full Text] [Related]

  • 3. Review of Non-Eosinophilic Esophagitis-Eosinophilic Gastrointestinal Disease (Non-EoE-EGID) and a Case Series of Twenty-Eight Affected Patients.
    Kinoshita Y, Sanuki T.
    Biomolecules; 2023 Sep 20; 13(9):. PubMed ID: 37759817
    [Abstract] [Full Text] [Related]

  • 4. Early life exposures as risk factors for non-esophageal eosinophilic gastrointestinal diseases.
    Jensen ET, Dai X, Kodroff E, Strobel MJ, Zicarelli A, Gray S, Cordell A, Anderson C, Hiremath G, Dellon ES.
    Clin Res Hepatol Gastroenterol; 2023 Aug 20; 47(7):102170. PubMed ID: 37352927
    [Abstract] [Full Text] [Related]

  • 5. Eosinophilic Esophagitis Patients Are Not at Increased Risk of Severe COVID-19: A Report From a Global Registry.
    Zevit N, Chehade M, Leung J, Marderfeld L, Dellon ES.
    J Allergy Clin Immunol Pract; 2022 Jan 20; 10(1):143-149.e9. PubMed ID: 34688963
    [Abstract] [Full Text] [Related]

  • 6. Dupilumab in adolescent eosinophilic esophagitis: Experience with fibrostenosis and eosinophilic gastrointestinal disease with esophageal involvement.
    Becker R, Rigsby M, Suchi M, Lerner DG, Chugh A.
    J Pediatr Gastroenterol Nutr; 2024 Jun 20; 78(6):1337-1341. PubMed ID: 38587127
    [Abstract] [Full Text] [Related]

  • 7. Eosinophil Involvement Outside the Esophagus in Eosinophilic Esophagitis.
    Sato H, Taylor RJ, Sakai N, Osonoi K, Rothenberg ME, Shoda T.
    Clin Gastroenterol Hepatol; 2024 Jul 20; 22(7):1531-1534.e2. PubMed ID: 38103874
    [Abstract] [Full Text] [Related]

  • 8. Esophageal Fibrosis in Eosinophilic Gastrointestinal Diseases.
    Thaker AI, Melo DM, Samandi LZ, Huang R, Park JY, Cheng E.
    J Pediatr Gastroenterol Nutr; 2021 Mar 01; 72(3):392-397. PubMed ID: 33230074
    [Abstract] [Full Text] [Related]

  • 9. Pharmacologic Management of Non-Eosinophilic Esophagitis Eosinophilic Gastrointestinal Diseases.
    Dellon ES, Gupta SK.
    Immunol Allergy Clin North Am; 2024 May 01; 44(2):397-406. PubMed ID: 38575232
    [Abstract] [Full Text] [Related]

  • 10. Elements Involved In Promoting Eosinophilic Gastrointestinal Disorders.
    Shukla A, Mishra A, Venkateshaiah SU, Manohar M, Mahadevappa CP, Mishra A.
    J Genet Syndr Gene Ther; 2015 Aug 01; 6(2):. PubMed ID: 27840774
    [Abstract] [Full Text] [Related]

  • 11. Review article: Emerging insights into the epidemiology, pathophysiology, diagnostic and therapeutic aspects of eosinophilic oesophagitis and other eosinophilic gastrointestinal diseases.
    Low EE, Dellon ES.
    Aliment Pharmacol Ther; 2024 Feb 01; 59(3):322-340. PubMed ID: 38135920
    [Abstract] [Full Text] [Related]

  • 12. High Patient Disease Burden in a Cross-sectional, Multicenter Contact Registry Study of Eosinophilic Gastrointestinal Diseases.
    Jensen ET, Aceves SS, Bonis PA, Bray K, Book W, Chehade M, Collins MH, Dellon ES, Falk GW, Gonsalves N, Gupta SK, Hirano I, Katzka DA, Kyle S, Mack D, Kodroff E, Leung J, Mukkada VA, Scott M, Paliana A, Sable K, Spergel JM, Strobel MJ, Krischer J, Rothenberg ME, Abonia P, CEGIR Investigator group.
    J Pediatr Gastroenterol Nutr; 2020 Oct 01; 71(4):524-529. PubMed ID: 32541201
    [Abstract] [Full Text] [Related]

  • 13. Eosinophilic gastrointestinal diseases with esophageal involvement: Analysis of 212 patients.
    Gratacós Gómez AR, Palacios Cañas A, Meneses Sotomayor J, Clar Castelló M, Muñoz Rodriguez JR, Gomez Torrijos E.
    Med Clin (Barc); 2023 Nov 10; 161(9):374-381. PubMed ID: 37524587
    [Abstract] [Full Text] [Related]

  • 14. Clinical Characteristics and Treatment Outcomes of Patients with Eosinophilic Esophagitis and Eosinophilic Gastroenteritis.
    Okimoto E, Ishimura N, Ishihara S.
    Digestion; 2021 Nov 10; 102(1):33-40. PubMed ID: 33202408
    [Abstract] [Full Text] [Related]

  • 15. Racial differences in eosinophilic gastrointestinal disorders among Caucasian and Asian.
    Ito J, Fujiwara T, Kojima R, Nomura I.
    Allergol Int; 2015 Jul 10; 64(3):253-9. PubMed ID: 26117257
    [Abstract] [Full Text] [Related]

  • 16. Eosinophilic gastrointestinal disorders in patients with inborn errors of immunity: Data from the USIDNET registry.
    Tran P, Gober L, Garabedian EK, Fuleihan RL, Puck JM, Sullivan KE, Spergel JM, Ruffner MA.
    Front Immunol; 2022 Jul 10; 13():987895. PubMed ID: 36211419
    [Abstract] [Full Text] [Related]

  • 17. The impact of COVID-19 on Japanese patients with eosinophilic gastrointestinal disorders during the vaccination era.
    Fujiwara Y, Sawada A, Higashimori A, Nakata R, Tanoue K, Nishida Y, Maruyama H, Ominami M, Fukunaga S, Otani K, Hosomi S, Kamata N, Tanaka F, Nagami Y, Taira K.
    JGH Open; 2023 Oct 10; 7(10):702-707. PubMed ID: 37908294
    [Abstract] [Full Text] [Related]

  • 18. A Case Series on the Use of Dupilumab for Treatment of Refractory Eosinophilic Gastrointestinal Disorders.
    Patel N, Goyal A, Thaker A, Troendle D, Parrish C.
    J Pediatr Gastroenterol Nutr; 2022 Aug 01; 75(2):192-195. PubMed ID: 35666881
    [Abstract] [Full Text] [Related]

  • 19. Comparison of Nonesophageal Eosinophilic Gastrointestinal Disorders with Eosinophilic Esophagitis: A Nationwide Survey.
    Yamamoto M, Nagashima S, Yamada Y, Murakoshi T, Shimoyama Y, Takahashi S, Seki H, Kobayashi T, Hara Y, Tadaki H, Ishimura N, Ishihara S, Kinoshita Y, Morita H, Ohya Y, Saito H, Matsumoto K, Nomura I.
    J Allergy Clin Immunol Pract; 2021 Sep 01; 9(9):3339-3349.e8. PubMed ID: 34214704
    [Abstract] [Full Text] [Related]

  • 20. Model to Determine the Optimal Dietary Elimination Strategy for Treatment of Eosinophilic Esophagitis.
    Zhan T, Ali A, Choi JG, Lee M, Leung J, Dellon ES, Garber JJ, Hur C.
    Clin Gastroenterol Hepatol; 2018 Nov 01; 16(11):1730-1737.e2. PubMed ID: 29730438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.